These studies demonstrate that the inhibition of ICOS, ICOSL and CD28 and stimulation of CTLA-4 and its ligands in melanoma lung metastasis is mediated, at least in part, by a tumor-independent effect of CHI3L1. The gene discussed is ICOS; the disease is melanoma.